pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-539 |
Genomic Coordinates | chr14: 101047321 - 101047398 |
Synonyms | MIRN539, hsa-mir-539, MIR539 |
Description | Homo sapiens miR-539 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-539-3p | ||||||||||||||||||||||||||||
Sequence | 49| AUCAUACAAGGACAAUUUCUUU |70 | ||||||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | RREB1 | ||||||||||||||||||||
Synonyms | FINB, HNT, LZ321, RREB-1, Zep-1 | ||||||||||||||||||||
Description | ras responsive element binding protein 1 | ||||||||||||||||||||
Transcript | NM_001003698 | ||||||||||||||||||||
Other Transcripts | NM_001003699 , NM_001003700 , NM_001168344 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on RREB1 | |||||||||||||||||||||
3'UTR of RREB1 (miRNA target sites are highlighted) |
>RREB1|NM_001003698|3'UTR 1 CAGCCTCAGTCCCCCTCAGCACAGACAAAAGCCAGCAGAGCAAAGCGTCTATACTTCATGGGGTTTCCTCAGTGCCCTTT 81 GGCTGTTGAGGAGTGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGAGACAAGCAGGAGCGTGGCTGCTCGCT 161 CAGTGCCATAGCCTTACCGCAGCCTGCGCGGGAGGCCACAGCCCGTGCCGATTCCAGTGCCTTAACTACTTACCGGATCC 241 CTCCATATTATCATGGGTGTTGTATTTTTCCAAAATGACTTCTTAAACAAAACAAATATTATAATGAATTGTCTGGAGAG 321 GACCTCTTCATTTGAGCATTAGCGTTATTTTGTATTGGTGTGTGTGAGCTTGTTCTTGTGAATCTGTGATAGCACCGTTT 401 GTTCTGTGAGCTGGAAACAGAAGGAAAAAACATACCCTTGGGTACCCATAGCCAATAACTGGAAGAAAATGATGTGAATT 481 TCATGTAAATGACCAGAGGAAAGATGGATAAGATGATAATTTCTTAAATAGACATTTTCCTTTTTTCTTTGTGCTTCATG 561 GTGGAGCTGTCATCTGGTCCTTGGTATTACAGGATGTGGTTGATGAAGGTTTCCAATATGGTTTCAGGCCAAAACCAGGG 641 AAGATTCTAGCTTCAGCCTCATGTCCATTTCCAGTCTGTCAGCATTAGACATGGTCACTGTTCAAGTTTCAAGACATCCA 721 TTCTTAACTATAGAGAAGAGTTACTCCCCTGGCGTCTTAACCTATGGAAAACATGCACGGATAGGATATATTTGATTGCC 801 TCCTCTTCCCTTTCAGTATATGTATTATTAATATTATTATTATTATTATTATTATTAGTTCATCAGTTTGCTGTTCTCTG 881 CAGTGAGCAGAATCAAATGGGCAATATTTGTCCTGGGAGACCTGTGCCGCACCCAGGTCCCCGTGTTAACGTGTGCCTGC 961 GGTTGTGGTTGGCACCCTCGGGTGGTAGCTCTTCTACTGTAATGAGACAAGCCTTTCTTCTGTCACTGCAGAATTTAGAA 1041 GGGGCCGTGAGCAGTCTTCCCAAGCATGGTCCAGGAGCAGCTCAGAGAGGGTGGAGTGAGGATGCATGCATCCAGGGAAC 1121 AGGCATCAAGAAGCCAGGGCCGTGCCTGGAGCACTGCAGAGATGACTTTGGAGAAAGCAAAGCAGTGACCCAGTGACCAG 1201 GCACATTACTCGTGAGCGAGGTATTCCCAGTCTTCCTGCTAAGCCTAATCCAAGCCTTACCCAGCTGTGCTACTGTCATT 1281 TGCAAAGCAAGGAAATACTACTACTGGTAATAAAACTACACATGCAAGATGTCAGATAAGAAATAGGTTTATATTTACCT 1361 TCCTGCGATGTGGGGTTGGTGCTTGAAGATAAATGTGCTGTTTCTAGTTTCTTAAATAGCCCACACCCCTGGATGCAAAA 1441 AGGCAGGGTTATTTTTACCCATGAGCATCCTGTGCAGGCAATAGACTTCCCTCACTGTCTCCGCCTGCAGGGAGGAGAAT 1521 GTACCCCACTGCACCTGAGCTCCTGGTCCCTCAGCCAAGACCTCAGGGGTCCCCAGCCAGCCTGCTGCTGGGGACCCCTG 1601 TGCTTGCTGCAGTGTATGGAGCCTCTTGCCTTCCCCTGGGGAGGCACCCCTGTACCCCAGCTTCCTTCCCCTGGCCTTTT 1681 CTGGCCCCAGTGCTCCTCCTTTACATAGACTTGTTCACACAGAAACGTGCACGCCCCCTTTTCTCCGCCACTTCACCAGT 1761 TTCTGAAATCCAACCTCCCAGACTTCACAGGAAGATAGATATTCTTGAGATAATGAAAAGTGATATCTTCGCATACGAAA 1841 GGAAAAAAGGTTGAGGTATATATGATTTTTAACTGTATTAGGGGTGTATGAACCAGTTTAAAAACGAGGTTTTATTTACT 1921 GTAGAGATGAATGCAAATCAGAACCAATGATCCCTTGGCCTACTTAGTTAAAACCAGTTCATACATCCCTTAGGGTTTTT 2001 ATTATTATTATTATTATTATTACAGTTGTTATTGTTGTTTTTGTTGTTATTATTATTTGGGGTTTCTTGTGTTTTTTCTT 2081 TGCGACTCTCCACACTAAACTTGCAATATTGTGGGGAGAAGCTGTGACTAAACTCTACGCTGCGGTGAGATGTAGCAGTA 2161 ATCAGCTCCCAGCGACGTGTGTAGCTGGGGCTGCCGCTCGCAATAATCACTATTGATTTAAAGCTTTACTTAGCCTTGAT 2241 CTGTACCCTCGTAGTCAATAAGGTCTTGCCACATTTTATTAGTGAGGTGGAGAAACGTATTATTTGTTTGTTGTTTTTGC 2321 CCTTCCCCCACCCCCCAATATTAAACTGTGAAATTTGTGATTTGTTTAAACTCTGGGTGAATCATAGCTTAGTTTGCATG 2401 TCCAGCTAATTTGTTTCTATACATTTTGTTTGATTCTCTTTCTCCTTCTCTCAGGGCTTTTACAAAAAAATATATATATA 2481 TGGATCTTCTGAAAAGTTTTTTGAGGTGCAAGTTTTTTCTCTTTTTTTTTTTTTTTTTTTTTTCTCATTGATTAATGGAC 2561 ATGATGCTGAGATTCAATCACTACATGAAACACCTGGCTGTGAAAACAAAACAACCCAGAGGGCTGTGTTCCAAGCAGCG 2641 CTGGGGAAGCTACGTAACAGTCGGATGCCAGTTTTGGAAGATTCACCATGCGTTCTGACCCTCTGTTCGTCTCTTTCCTC 2721 TCCTCTTTCTTCAAGAAGGAAATTGATCCTAGTGATTTCAGCCCATGCATTAAACAGGAAACAATAATAAATTTGTAGAA 2801 TTCATATTTTTCTAAAGGGAACTTAAAAACTGCTGCTACATGTTATGTACAAAACTGGTTTATGCCACATGAACAGAGAA 2881 TCACAAGTTTGGTTTTGGTACTTTTTGTTCCTCTTTGTATTCAGTTGTATAGAACTTCCAAATTCAGAATGAGAAGAAAG 2961 CTGTTCTGTATCAAACCATTTAAGCAATAAATGTTATATTTTAAAAGCTGCA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000379938.2 | 3UTR | AUUUUUAACUGUAUUAGGGGUGUAUGAACCAGUUUAAAAACGAGGUUUUAUUUACUGUA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000379938.2 | 3UTR | AUUAGGGGUGUAUGAACC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000379938.2 | 3UTR | AUUUUUAACUGUAUUAGGGGUGUAUGAACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
65 hsa-miR-539-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT102192 | NAPEPLD | N-acyl phosphatidylethanolamine phospholipase D | 2 | 4 | ||||||||
MIRT147308 | KPNA2 | karyopherin subunit alpha 2 | 2 | 8 | ||||||||
MIRT255970 | WDR17 | WD repeat domain 17 | 2 | 2 | ||||||||
MIRT318225 | RREB1 | ras responsive element binding protein 1 | 2 | 4 | ||||||||
MIRT339123 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT341161 | HNRNPC | heterogeneous nuclear ribonucleoprotein C (C1/C2) | 2 | 2 | ||||||||
MIRT439452 | TMED10 | transmembrane p24 trafficking protein 10 | 1 | 1 | ||||||||
MIRT439861 | PTPRS | protein tyrosine phosphatase, receptor type S | 1 | 1 | ||||||||
MIRT440178 | MTRNR2L8 | MT-RNR2-like 8 | 1 | 1 | ||||||||
MIRT440188 | MTRNR2L2 | MT-RNR2-like 2 | 1 | 1 | ||||||||
MIRT440445 | INTS3 | integrator complex subunit 3 | 1 | 1 | ||||||||
MIRT440771 | DST | dystonin | 1 | 1 | ||||||||
MIRT440838 | DDX17 | DEAD-box helicase 17 | 1 | 1 | ||||||||
MIRT440928 | CLTC | clathrin heavy chain | 1 | 1 | ||||||||
MIRT441017 | CANX | calnexin | 1 | 1 | ||||||||
MIRT441020 | CAND1 | cullin associated and neddylation dissociated 1 | 1 | 1 | ||||||||
MIRT441272 | ACTR3C | ARP3 actin related protein 3 homolog C | 1 | 1 | ||||||||
MIRT441275 | ACTR3B | ARP3 actin related protein 3 homolog B | 1 | 1 | ||||||||
MIRT446564 | IDS | iduronate 2-sulfatase | 2 | 2 | ||||||||
MIRT458674 | MRI1 | methylthioribose-1-phosphate isomerase 1 | 2 | 2 | ||||||||
MIRT467486 | SMIM13 | small integral membrane protein 13 | 2 | 2 | ||||||||
MIRT471515 | PCGF3 | polycomb group ring finger 3 | 2 | 6 | ||||||||
MIRT488211 | TESK2 | testis-specific kinase 2 | 2 | 6 | ||||||||
MIRT505413 | TCF7L2 | transcription factor 7 like 2 | 2 | 4 | ||||||||
MIRT506405 | NRF1 | nuclear respiratory factor 1 | 2 | 4 | ||||||||
MIRT508095 | ANKRD33B | ankyrin repeat domain 33B | 2 | 4 | ||||||||
MIRT511883 | GAS1 | growth arrest specific 1 | 2 | 6 | ||||||||
MIRT513413 | RTP4 | receptor transporter protein 4 | 2 | 2 | ||||||||
MIRT515814 | FOCAD | focadhesin | 2 | 2 | ||||||||
MIRT522747 | LNPEP | leucyl and cystinyl aminopeptidase | 2 | 2 | ||||||||
MIRT526664 | IL5RA | interleukin 5 receptor subunit alpha | 2 | 6 | ||||||||
MIRT532113 | G6PC | glucose-6-phosphatase catalytic subunit | 2 | 2 | ||||||||
MIRT547536 | MAML3 | mastermind like transcriptional coactivator 3 | 2 | 2 | ||||||||
MIRT554605 | RPS6KA5 | ribosomal protein S6 kinase A5 | 2 | 2 | ||||||||
MIRT554884 | RCAN2 | regulator of calcineurin 2 | 2 | 2 | ||||||||
MIRT555859 | PANK3 | pantothenate kinase 3 | 2 | 2 | ||||||||
MIRT556601 | LDOC1L | retrotransposon Gag like 6 | 2 | 4 | ||||||||
MIRT565169 | LINC00598 | long intergenic non-protein coding RNA 598 | 2 | 2 | ||||||||
MIRT567099 | KANSL1 | KAT8 regulatory NSL complex subunit 1 | 2 | 2 | ||||||||
MIRT575032 | Fasl | Fas ligand (TNF superfamily, member 6) | 1 | 1 | ||||||||
MIRT609327 | TAS2R30 | taste 2 receptor member 30 | 2 | 4 | ||||||||
MIRT609394 | C11orf74 | chromosome 11 open reading frame 74 | 2 | 2 | ||||||||
MIRT613120 | SRCAP | Snf2 related CREBBP activator protein | 2 | 2 | ||||||||
MIRT614273 | WSCD2 | WSC domain containing 2 | 2 | 2 | ||||||||
MIRT614988 | GID4 | GID complex subunit 4 homolog | 2 | 4 | ||||||||
MIRT619483 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 2 | ||||||||
MIRT622061 | SS18 | SS18, nBAF chromatin remodeling complex subunit | 2 | 2 | ||||||||
MIRT627045 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT657273 | HS3ST3B1 | heparan sulfate-glucosamine 3-sulfotransferase 3B1 | 2 | 2 | ||||||||
MIRT658285 | FASLG | Fas ligand | 2 | 3 | ||||||||
MIRT660838 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT665552 | UCHL5 | ubiquitin C-terminal hydrolase L5 | 2 | 2 | ||||||||
MIRT687560 | MGAT5 | mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase | 2 | 2 | ||||||||
MIRT698864 | SRSF2 | serine and arginine rich splicing factor 2 | 2 | 2 | ||||||||
MIRT699509 | SKIL | SKI like proto-oncogene | 2 | 2 | ||||||||
MIRT706255 | MKLN1 | muskelin 1 | 2 | 2 | ||||||||
MIRT711973 | HOMER2 | homer scaffolding protein 2 | 2 | 2 | ||||||||
MIRT718038 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718766 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 | ||||||||
MIRT721319 | GRHL1 | grainyhead like transcription factor 1 | 2 | 2 | ||||||||
MIRT721439 | NGDN | neuroguidin | 2 | 2 | ||||||||
MIRT721977 | RAD50 | RAD50 double strand break repair protein | 2 | 2 | ||||||||
MIRT725374 | MTF2 | metal response element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT737461 | CTBP1 | C-terminal binding protein 1 | 4 | 0 | ||||||||
MIRT755390 | Sox9 | SRY-box 9 | 4 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|